Search

Maximilian Muenke Phones & Addresses

  • 329 Bryn Mawr Ave, Bala Cynwyd, PA 19004 (610) 660-0162 (610) 660-0251
  • 5131 Dudley Ct, Bethesda, MD 20814 (301) 571-5357
  • Lansdowne, PA
  • Fredericksburg, VA
  • Hazel Green, AL

Languages

English

Awards

Healthgrades Honor Roll

Ranks

Certificate: Clinical Cytogenetics, 2006

Specialities

Clinical Genetics • Clinical Cytogenetics • Clinical Molecular Genetics

Professional Records

Medicine Doctors

Maximilian Muenke Photo 1

Dr. Maximilian Muenke, Bethesda MD - MD (Doctor of Medicine)

View page
Specialties:
Clinical Genetics
Clinical Cytogenetics
Clinical Molecular Genetics
Address:
5131 Dudley Ln, Bethesda, MD 20814
(301) 273-5250 (Phone)
Certifications:
Clinical Cytogenetics, 2006
Clinical Genetics, 2006
Clinical Molecular Genetics, 2010
Awards:
Healthgrades Honor Roll
Languages:
English

License Records

Maximilian Muenke

License #:
MT017529T - Expired
Category:
Medicine
Type:
Graduate Medical Trainee

Maximilian Muenke

Address:
Bala Cynwyd, PA 19004
License #:
MD040772L - Active
Category:
Medicine
Type:
Medical Physician and Surgeon

Maximilian Muenke

Address:
Bala Cynwyd, PA 19004
License #:
PAK000079 - Active
Category:
Medicine
Type:
Physician Acupuncturist

Business Records

Name / Title
Company / Classification
Phones & Addresses
Maximilian Muenke
Principal
Medical Acupuncture and Complementary Me
Health Practitioner's Office
329 Bryn Mawr Ave, Cynwyd, PA 19004
Maximilian Muenke
Maximilian Muenke MD,DABMA
Genetic Medicine
329 Bryn Mawr Ave, Bala Cynwyd, PA 19004
(610) 256-4103

Publications

Us Patents

Methods For Detecting And Treating Attention-Deficit/Hyperactivity Disorder

View page
US Patent:
20100040626, Feb 18, 2010
Filed:
Sep 27, 2007
Appl. No.:
12/444898
Inventors:
Maximilian Muenke - Bala Cynwyd PA, US
F. Xavier Castellanos - New York NY, US
Assignee:
The United States of America, as represented by the Secretary, Dept. of Health and Human Services - Bethesda MD
International Classification:
A61K 39/395
C12Q 1/68
C12P 19/34
A61K 38/02
A61P 25/00
US Classification:
4241411, 435 6, 435 912, 514 2, 4241301
Abstract:
The invention provides a method of determining a susceptibility of a subject for development of ADHD. The method comprises obtaining a sample from the subject, analyzing the sample for an ADHD susceptibility haplotype of LPHN3 receptor which is associated with at least one genetic marker selected from the group consisting of rs7678046, rs1901223, rs6813183, and rs1355368, and determining if the subject has a susceptibility to develop ADHD, whereby the presence of the haplotype having one or more of the genetic markers is indicative of a susceptibility to develop ADHD. The invention also provides methods of treating ADHD.

Methods For Detecting Adhd Susceptibility And Predicting Severity And Long Term Outcome Of Adhd Symptoms

View page
US Patent:
20130012497, Jan 10, 2013
Filed:
May 18, 2012
Appl. No.:
13/475342
Inventors:
Maximilian Muenke - Bala Cynwyd PA, US
Mauricio Arcos-Burgos - Canberra, AU
Maria Teresa Acosta - Bethesda MD, US
Assignee:
The United States of America, as represented by the Secretary, Department of Health and Human Ser. - Bethesda MD
International Classification:
C40B 30/04
A61K 31/519
A61K 31/165
C12Q 1/68
A61K 31/55
A61K 31/135
A61P 25/26
A61P 25/24
A61K 31/4168
A61K 31/137
US Classification:
514217, 514398, 51425941, 514618, 514654, 514656, 506 9, 435 611
Abstract:
The invention provides methods of determining an altered susceptibility to develop ADHD, methods of predicting or determining the severity of symptoms of ADHD and associated disorders, and methods of treatment based on the presence or absence of one or more alleles of single nucleotide polymorphism (SNP) markers.
Maximilian Muenke from Bala Cynwyd, PA, age ~72 Get Report